# US 2022/0011304 A1 · Biosensor and method for detection of analytes

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0011304 A1
- Document ID: US20220011304A1
- Status: Published application
- Kind: A1
- Application number: 17/297,385
- Filed: 2018-12-20
- Published: 2022-01-13
- Earliest claimed: 2018-12-03
- Assignees: University of Notre Dame du Lac
- Applicants: University of Notre Dame Du Lac
- Inventors: Jiayun Hu; Paul W. Bohn; Marvin J. Miller; Manuka Ghosh
- Web page: https://patentgrep.com/patent/US20220011304A1

## CPC

- G01N 33/54346: {Nanoparticles}
- G01N 33/54373: {involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings}
- C12N 15/115: Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith {; Nucleic acids binding to non-nucleic acids, e.g. aptamers}
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- G01N 21/658: {enhancement Raman, e.g. surface plasmons}
- G01N 33/5308: {for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites}
- G01N 33/553: Metal or metal coated
- G01N 33/56911: {Bacteria}
- B82Y 30/00: Nanotechnology for materials or surface science, e.g. nanocomposites
- C12N 2310/16: Aptamers
- G01N 2333/21: from Pseudomonadaceae (F)
- G01N 2333/22: from Neisseriaceae (F), e.g. Acinetobacter
- G01N 2800/26: Infectious diseases, e.g. generalised sepsis
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- B82Y: SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES

## Abstract

Described is a biosensor for detection of analytes and methods of using the same for detecting bacterial infection in a subject. The biosensor comprises an array of gold nanoparticles, biotinylated polyethylene glycol thiol, polyethylene glycol thiol, at least one neutravidin molecule, and at least one affinity reagent immobilized on a surface of the at least one neutravidin molecule. The affinity reagent may be an aptamer or a siderophore. The biosensors demonstrate extraordinary selectively and sensitivity for rapid detection of whole-cell bacteria.

## Claims

### Claim 1

A biosensor for detection of analytes, the biosensor comprising:
a. an array of gold nanoparticles;
b. biotinylated polyethylene glycol thiol in direct contact with one or more of the gold nanoparticles;
c. polyethylene glycol thiol in direct contact with one or more of the gold nanoparticles;
d. at least one neutravidin molecule immobilized on a surface of the biotinylated polyethylene glycol thiol; and
e. at least one affinity reagent immobilized on a surface of the at least one neutravidin molecule.

### Claim 2 (depends on 1)

The biosensor of claim 1, wherein the array of gold nanoparticles comprises gold nanotriangles.

### Claim 3 (depends on 1)

The biosensor of claim 1, wherein the biosensor comprises a hexagonal array of gold nanoparticles.

### Claim 4 (depends on 1)

The biosensor of claim 1, wherein the biosensor comprises biotinylated polyethylene glycol thiol and polyethylene glycol thiol in a ratio of about 1:3 by volume.

### Claim 5 (depends on 1)

The biosensor of claim 1, wherein the affinity reagent is a biotinylated aptamer.

### Claim 6 (depends on 5)

The biosensor of claim 5, wherein the biotinylated aptamer selectively binds Pseudomonas aeruginosa.

### Claim 7 (depends on 6)

The biosensor of claim 6, wherein the biotinylated aptamer selectively binds Pseudomonas aeruginosa strain PAO1.

### Claim 8 (depends on 7)

The biosensor of claim 7, wherein the biotinylated aptamer is encoded by the nucleotide sequence of SEQ ID NO: 1.

### Claim 9 (depends on 1)

The biosensor of claim 1, wherein the affinity reagent is a biotinylated siderophore.

### Claim 10 (depends on 9)

The biosensor of claim 9, wherein the biotinylated siderophore is a biscatecholate-monohydroxamate mixed ligand siderophore.

### Claim 11 (depends on 10)

The biosensor of claim 10, wherein the biscatecholate-monohydroxamate mixed ligand siderophore comprises three repeating polyethylene glycol units linked to a biotin molecule.

### Claim 12 (depends on 9)

The biosensor of claim 9, wherein the biotinylated siderophore selectively binds Acinetobacter baumannii.

### Claim 13 (depends on 12)

A method of detecting one or more whole bacterial cells in a sample, the method comprising contacting the sample with the biosensor of claim 12.

### Claim 14

A method of detecting a bacterial infection in a subject, the method comprising:
a. obtaining a sample from the subject;
b. contacting the sample with a biosensor, wherein the biosensor comprises
i. an array of gold nanoparticles;
ii. biotinylated polyethylene glycol thiol in direct contact with one or more of the gold nanoparticles;
iii. polyethylene glycol thiol in direct contact with one or more of the gold nanoparticles;
iv. at least one neutravidin molecule immobilized on a surface of the biotinylated polyethylene glycol thiol; and
v. at least one affinity reagent immobilized on a surface of the at least one neutravidin molecule;
c. detecting a localized surface plasmon resonance wavelength of the sample; and
d. comparing the localized surface plasmon resonance wavelength of the sample to a localized surface plasmon resonance wavelength in a control sample,
wherein a shift in the wavelength of maximum extinction of the localized surface plasmon resonance of the sample relative to the wavelength of maximum extinction of the localized surface plasmon resonance of the control sample indicates a bacterial infection in the subject.

### Claim 15 (depends on 14)

The method of claim 14, wherein the array of gold nanoparticles comprises gold nanotriangles.

### Claim 16 (depends on 14)

The method of claim 14, wherein the biosensor comprises a hexagonal array of gold nanoparticles.

### Claim 17 (depends on 14)

The method of claim 14, wherein the biosensor comprises biotinylated polyethylene glycol thiol and polyethylene glycol thiol in a ratio of about 1:3 by volume.

### Claim 18 (depends on 14)

The method of claim 14, wherein the affinity reagent is a biotinylated aptamer.

### Claim 19 (depends on 14)

The method of claim 14, wherein the biotinylated aptamer selectively binds Pseudomonas aeruginosa.

### Claim 20 (depends on 19)

The method of claim 19, wherein the biotinylated aptamer selectively binds Pseudomonas aeruginosa strain PAO1.

### Claim 21 (depends on 20)

The method of claim 20, wherein the biotinylated aptamer is encoded by the nucleotide sequence of SEQ ID NO: 1.

### Claim 22 (depends on 14)

The method of claim 14, wherein the affinity reagent is a biotinylated siderophore.

### Claim 23 (depends on 22)

The method of claim 22, wherein the biotinylated siderophore is a biscatecholate-monohydroxamate mixed ligand siderophore.

### Claim 24 (depends on 23)

The method of claim 23, wherein the biscatecholate-monohydroxamate mixed ligand siderophore comprises three repeating polyethylene glycol units linked to a biotin molecule.

### Claim 25 (depends on 22)

The method of claim 22, wherein the biotinylated siderophore selectively binds Acinetobacter baumannii.

### Claim 26 (depends on 14)

The method of claim 14, wherein a concentration of bacteria of about 4×106 cfu/mL or less produces a positive shift in the wavelength of maximum extinction of the localized surface plasmon resonance of the sample, indicating bacterial infection in the subject.

### Claim 27 (depends on 14)

The method of claim 14, wherein the method detects a bacterial infection in the subject in approximately 3 hours.

### Claim 28 (depends on 14)

The method of claim 14, wherein the bacterial infection in the subject is a Pseudomonas aeruginosa infection or an Acinetobacter baumannii infection.
